ZYLOX-TONBRDG.MED.TECH.H1 (818) — Free Cash Flow Generation Index

Latest as of December 2024: -0.10x

ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Free Cash Flow Generation Index of -0.10x as of December 2024. Free cash flow of €-17.26 Million represents 0% of operating cash flow (€174.08 Million). See ZYLOX-TONBRDG.MED.TECH.H1 (818) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-0.10x
Free Cash Flow / Operating CF

Free Cash Flow

€-17.26 Million
EUR

Operating Cash Flow

€174.08 Million
EUR

Capital Expenditures

€191.34 Million
EUR

ZYLOX-TONBRDG.MED.TECH.H1 Free Cash Flow Generation Index (2023–2024)

Historical FCF Generation Index trend for ZYLOX-TONBRDG.MED.TECH.H1 across 2 annual periods. Explore ZYLOX-TONBRDG.MED.TECH.H1 (818) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for ZYLOX-TONBRDG.MED.TECH.H1 (2023–2024)

Year-by-year Free Cash Flow Generation Index for ZYLOX-TONBRDG.MED.TECH.H1. For the full company profile including market capitalisation, see 818 market cap overview.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2024 -0.10x €-17.26 Million €174.08 Million €191.34 Million ▲ +89.4%
2023 -0.94x €-92.48 Million €98.44 Million €190.92 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).